Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 107 of the 109 references it cites were found in a registry or an index.

Primary cilia-mediated regulation of microglial secretion in Alzheimer’s disease

Open access
Yeo, Seungeun, Jang, Jaemyung, Jung, Hyun Jin, Lee, Hyeyoung, Choe, Youngshik · 2023 · Frontiers in Molecular Biosciences

Abstract

Graphical Abstract: Microglial phagocytosis and exocytosis of Aβ are mediated by primary cilia, which influence extracellular proteostasis, Aβ plaque formation, and neurite dystrophy. When microglia in wild-type mice develop into the disease-associated state, they require genes involved in primary ciliogenesis and extracellular vesicle secretion. Inhibition of Ift88, a key cilia gene, in microglia stimulates phagocytosis and the secretion of extracellular vesicles with an altered proteomic composition, leading to the failure of extracellular proteostasis and neurite degeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmolb.2023.1250335

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract Microglial phagocytosis and exocytosis of Aβ are mediated by primary cilia, which influence extracellular proteostasis, Aβ plaque formation, and neurite dystrophy. When microglia in wild-type mice develop into the disease-associated state, they require genes involved in primary ciliogenesis and extracellular vesicle secretion. Inhibition of Ift88, a key cilia gene, in microglia stimulates phagocytosis and the secretion of extracellular vesicles with an altered proteomic composition, leading to the failure of extracellular proteostasis and neurite degeneration.
Graphical abstract Microglial phagocytosis and exocytosis of Aβ are mediated by primary cilia, which influence extracellular proteostasis, Aβ plaque formation, and neurite dystrophy. When microglia in wild-type mice develop into the disease-associated state, they require genes involved in primary ciliogenesis and extracellular vesicle secretion. Inhibition of Ift88, a key cilia gene, in microglia stimulates phagocytosis and the secretion of extracellular vesicles with an altered proteomic composition, leading to the failure of extracellular proteostasis and neurite degeneration.CC BY · PubMed Central
FIGURE 1 Visualization of differential axonal spheroid formation in 5xFAD mice using AAV tracers (A) A schematic drawing depicts the injection of AAV-GFP into the vDG to trace the axonal projection into the LS. (B) Whole-brain imaging exhibits each track of AAV injected into the vDG, the LS, and the mPFC (6-month-old, WT, n = 4, female). The representative neuronal projections of each injected site were visualized: LS to Hb (LS → Hb), vDG to LS (vDG → LS), and mPFC to the NAc and CP (mPFC→ NAc/CP) of mice. Each black bar in the schematic drawings indicates the AAV-injected position. Allen brain atlas was used as a reference for mouse three-dimensional images (pink). (C) Representative images of an AAV-injected vDG region and the axonal target region in the LS are presented. Aβ plaques were stained using anti- Aβ antibodies (D54D2, red), and AAV-EGFP tracers were stained for EGFP (6-month-old, n = 4, each group, female). (D) Representative images of the AAV-injected LS and its main axonal target in the Hb (6-month-old, n = 4, each group, female) (E) Representative images of the AAV-injected mPFC and its major axonal targets, such as the NAc and CP of WT and 5xFAD mice (6-month-old). Imaging of AAV-injected mice was conducted 3 weeks after stereotaxic injection (6-month-old, n = 4, each group, female). (F∼H) Representative images of axonal spheroids and Aβ plaques (D54D2, red) at the AAV-injected sites and the axonal target sites (F, vDG → LS; G, LS → Hb; H, mPFC→ NAc). (I) A plot depicts the number of axonal spheroids/Aβ plaque in each projection: vDG → LS, mPFC → NAc, mPFC → CP, and LS → Hb. Data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. **p < 0.01, *p < 0.05. Scale bars = 2 mm (B); 100 µm (C∼E); 10 µm (F∼H).
FIGURE 1 Visualization of differential axonal spheroid formation in 5xFAD mice using AAV tracers (A) A schematic drawing depicts the injection of AAV-GFP into the vDG to trace the axonal projection into the LS. (B) Whole-brain imaging exhibits each track of AAV injected into the vDG, the LS, and the mPFC (6-month-old, WT, n = 4, female). The representative neuronal projections of each injected site were visualized: LS to Hb (LS → Hb), vDG to LS (vDG → LS), and mPFC to the NAc and CP (mPFC→ NAc/CP) of mice. Each black bar in the schematic drawings indicates the AAV-injected position. Allen brain atlas was used as a reference for mouse three-dimensional images (pink). (C) Representative images of an AAV-injected vDG region and the axonal target region in the LS are presented. Aβ plaques were stained using anti- Aβ antibodies (D54D2, red), and AAV-EGFP tracers were stained for EGFP (6-month-old, n = 4, each group, female). (D) Representative images of the AAV-injected LS and its main axonal target in the Hb (6-month-old, n = 4, each group, female) (E) Representative images of the AAV-injected mPFC and its major axonal targets, such as the NAc and CP of WT and 5xFAD mice (6-month-old). Imaging of AAV-injected mice was conducted 3 weeks after stereotaxic injection (6-month-old, n = 4, each group, female). (F∼H) Representative images of axonal spheroids and Aβ plaques (D54D2, red) at the AAV-injected sites and the axonal target sites (F, vDG → LS; G, LS → Hb; H, mPFC→ NAc). (I) A plot depicts the number of axonal spheroids/Aβ plaque in each projection: vDG → LS, mPFC → NAc, mPFC → CP, and LS → Hb. Data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. **p < 0.01, *p < 0.05. Scale bars = 2 mm (B); 100 µm (C∼E); 10 µm (F∼H).CC BY · PubMed Central
FIGURE 2 Differential trajectories of DAM from WT microglia were analyzed using the scRNAseq dataset. (A), (upper) UMAPs depict 144,185 cells sequenced from 16 samples of the hippocampus (88,011 cells), 4 samples of the septum (20,952 cells), and 7 samples of the Hb (35,222 cells), colored by each cell type (left) and highlighting a microglia-specific cluster (right). (A), (lower) UMAP depicts subclusters of 1,660 microglia selected from (A) representing each cell obtained from WT (366 cells at 3 months, 124 cells at 5 months, 26 cells at 6 months, 240 cells at 9 months, and 292 cells 12 months) and 5xFAD (201 cells at 3 months, 337 cells at 5 months, and 74 cells at 6 months) (B) Kernel density estimation with the Nebulosa package (Alquicira-Hernandez and Powell, 2021) shows the distribution of three homeostatic microglial feature genes (top) and six DAM feature genes (middle and bottom). (C) Trajectory plots showing the bifurcation of microglial progression into two principal trajectories (R: main root node, A: end node of Route A, B: end node of Route B, colored by pseudotime (D) Venn diagram of genes significantly associated with pseudotime in each trajectory (E) Trem2 gene expression along pseudotime in Route A (solid line) and Route B (dotted line) (F) Heatmap showing five clustered expressions of genes significantly associated with pseudotime in Route A and Route B. The root was set by microglia in the MG-02 cell cluster of 3-month-old WT mice.
FIGURE 2 Differential trajectories of DAM from WT microglia were analyzed using the scRNAseq dataset. (A), (upper) UMAPs depict 144,185 cells sequenced from 16 samples of the hippocampus (88,011 cells), 4 samples of the septum (20,952 cells), and 7 samples of the Hb (35,222 cells), colored by each cell type (left) and highlighting a microglia-specific cluster (right). (A), (lower) UMAP depicts subclusters of 1,660 microglia selected from (A) representing each cell obtained from WT (366 cells at 3 months, 124 cells at 5 months, 26 cells at 6 months, 240 cells at 9 months, and 292 cells 12 months) and 5xFAD (201 cells at 3 months, 337 cells at 5 months, and 74 cells at 6 months) (B) Kernel density estimation with the Nebulosa package (Alquicira-Hernandez and Powell, 2021) shows the distribution of three homeostatic microglial feature genes (top) and six DAM feature genes (middle and bottom). (C) Trajectory plots showing the bifurcation of microglial progression into two principal trajectories (R: main root node, A: end node of Route A, B: end node of Route B, colored by pseudotime (D) Venn diagram of genes significantly associated with pseudotime in each trajectory (E) Trem2 gene expression along pseudotime in Route A (solid line) and Route B (dotted line) (F) Heatmap showing five clustered expressions of genes significantly associated with pseudotime in Route A and Route B. The root was set by microglia in the MG-02 cell cluster of 3-month-old WT mice.CC BY · PubMed Central
FIGURE 3 Differential regulation of genes regulating ciliogenesis and secretion in septum- and hippocampus-enriched microglia (A) MG-01 (belonging to Route A, septum enriched, upper), MG-03 (belonging to Route B, hippocampus enriched, bottom), MG-10 (belonging to Route B, hippocampus enriched) cell clusters in WT mice, colored by each subcluster (B) Four-way plots showing differential expression analysis between 5xFAD and WT mice in the cell population of Route A and the cell population of Route B. Red dots indicate a mean fold change higher than 0.25 and a p-value less than 0.05, whereas blue dots indicate a fold change less than 0.25 and a p-value less than 0.05. (C) Heatmap showing gene scores calculated by 14 DAM, 20 ATM, and 20 IRM feature genes. The columns in the heatmap represent the MG-01, the MG-02, the MG-03, and the MG-10 cell cluster. (D) Volcano plots depicting the differentially expressed genes observed in the comparison between MG-01 and MG-03 versus MG-02 in WT mice. Differentially expressed gene analysis yielded 8 upregulated genes and 99 downregulated genes in the MG-01, 109 upregulated genes and 413 downregulated genes in the MG-03 cell cluster (Genes marked with red dots have an absolute value of average fold change greater than 0.25 and an adjust p-value less than 0.1). Among these genes, those highlighted in red are the ones that overlapped with genes listed in CiliaCarta. (E) Bar graph showing GSEA based on the GO and the Reactome database for both MG-01 and MG-03 clusters. For the MG-01, GSEA identified 19 pathways based on the GO-CC, 16 pathways based on the GO-BP, 3 pathways based on the Reactome (p-value less than 0.01). For the MG-03, GSEA revealed 29 pathways based on the GO-CC and 38 pathways based on the GO-BP (p-value less than 0.01). The bar graph represents the results of a keyword search within these pathways, highlighting terms such as “wound,” “cilium,” “inflammatory,” “complement,” “hemostasis,” “secretory,” “vesicle,” “vacuole,” “endosome,” “lysosome,” and “exosome.”
FIGURE 3 Differential regulation of genes regulating ciliogenesis and secretion in septum- and hippocampus-enriched microglia (A) MG-01 (belonging to Route A, septum enriched, upper), MG-03 (belonging to Route B, hippocampus enriched, bottom), MG-10 (belonging to Route B, hippocampus enriched) cell clusters in WT mice, colored by each subcluster (B) Four-way plots showing differential expression analysis between 5xFAD and WT mice in the cell population of Route A and the cell population of Route B. Red dots indicate a mean fold change higher than 0.25 and a p-value less than 0.05, whereas blue dots indicate a fold change less than 0.25 and a p-value less than 0.05. (C) Heatmap showing gene scores calculated by 14 DAM, 20 ATM, and 20 IRM feature genes. The columns in the heatmap represent the MG-01, the MG-02, the MG-03, and the MG-10 cell cluster. (D) Volcano plots depicting the differentially expressed genes observed in the comparison between MG-01 and MG-03 versus MG-02 in WT mice. Differentially expressed gene analysis yielded 8 upregulated genes and 99 downregulated genes in the MG-01, 109 upregulated genes and 413 downregulated genes in the MG-03 cell cluster (Genes marked with red dots have an absolute value of average fold change greater than 0.25 and an adjust p-value less than 0.1). Among these genes, those highlighted in red are the ones that overlapped with genes listed in CiliaCarta. (E) Bar graph showing GSEA based on the GO and the Reactome database for both MG-01 and MG-03 clusters. For the MG-01, GSEA identified 19 pathways based on the GO-CC, 16 pathways based on the GO-BP, 3 pathways based on the Reactome (p-value less than 0.01). For the MG-03, GSEA revealed 29 pathways based on the GO-CC and 38 pathways based on the GO-BP (p-value less than 0.01). The bar graph represents the results of a keyword search within these pathways, highlighting terms such as “wound,” “cilium,” “inflammatory,” “complement,” “hemostasis,” “secretory,” “vesicle,” “vacuole,” “endosome,” “lysosome,” and “exosome.”CC BY · PubMed Central
FIGURE 4 Repression of microglial primary cilia in 5xFAD mice (A) Representative images of AC3 (green)-positive microglia (MG) stained for Iba1 (red) in the LS and the cortex of WT and 5xFAD mice (6-month-old). In 5xFAD mice, Aβ plaques were stained using 6E10 antibodies (white). (B) Plots depict the percentage of AC3-positive microglia and the length of AC3-stained primary cilia, respectively. Images were taken from the LS (1024 ㎛2) and the cortex (1024 ㎛2) of WT and 5xFAD mice (5-month-old, n = 4, each group, male) (C) Western blot analysis shows the differential expression of the homeostatic microglial markers in BV2 cells, which were harvested 24 h after transfection with siIft88. Plots represent protein expression normalized by α-tubulin (αTub, n = 3). (D) Western blot analysis shows the differential expression of the DAM markers in BV2 cells transfected with siIft88 for 24 h. Plots represent protein expression normalized by αTub (n = 3). (B–D) Data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns (non-significant). Scale bars = 10 µm.
FIGURE 4 Repression of microglial primary cilia in 5xFAD mice (A) Representative images of AC3 (green)-positive microglia (MG) stained for Iba1 (red) in the LS and the cortex of WT and 5xFAD mice (6-month-old). In 5xFAD mice, Aβ plaques were stained using 6E10 antibodies (white). (B) Plots depict the percentage of AC3-positive microglia and the length of AC3-stained primary cilia, respectively. Images were taken from the LS (1024 ㎛2) and the cortex (1024 ㎛2) of WT and 5xFAD mice (5-month-old, n = 4, each group, male) (C) Western blot analysis shows the differential expression of the homeostatic microglial markers in BV2 cells, which were harvested 24 h after transfection with siIft88. Plots represent protein expression normalized by α-tubulin (αTub, n = 3). (D) Western blot analysis shows the differential expression of the DAM markers in BV2 cells transfected with siIft88 for 24 h. Plots represent protein expression normalized by αTub (n = 3). (B–D) Data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns (non-significant). Scale bars = 10 µm.CC BY · PubMed Central
FIGURE 5 Promotion of phagocytosis and EV secretion in BV2 cells by silencing of Ift88 (A) A representative western blot result of Ift88, CD63, and CD81, analyzed using lysates of BV2 cells transfected with siCon or siIft88. (B) Plots depict the expression of Ift88, CD63, and CD81 from western blots in (A) (n = 3). (C) A representative western blot result of CD63 and CD81, analyzed using EVs isolated from the conditioned medium of BV2 cells transfected with siCon or siIft88. (D) Plots depict the expression of CD63 and CD81 from western blots in (C) (n = 3). (E) Western blot analysis of Aβ uptake, analyzed using lysates of BV2 cells transfected with siCon or siIft88, followed by treatment with 1 μM Aβ for 18 h. A plot depicts Aβ in cell lysates (n = 3). (F) Western blot analysis of Aβ secretion in EVs, analyzed using the EVs collected from the conditioned medium of the BV2 cells transfected with siCon or siIft88, followed by treatment with 1 μM Aβ for 18 h. A plot depicts the Aβ obtained in EVs (n = 4). (G) Representative images of Aβ phagocytosis and lysosome activity in BV2 cells after Ift88 inhibition. BV2 cells were transfected with siCon or siIft88, followed by treatment with 1 µM pHrodo-Aβ for 18 h. Fixed cells were stained for pHrodo-Aβ and LysoTracker to visualize the phagocytosis activity and lysosome activity, respectively. (H), (I) Plots depict the relative intensity of pHrodo-Aβ (H) and LysoTracker (I) (n = 4). Data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns (non-significant). Scale bars = 10 µm.
FIGURE 5 Promotion of phagocytosis and EV secretion in BV2 cells by silencing of Ift88 (A) A representative western blot result of Ift88, CD63, and CD81, analyzed using lysates of BV2 cells transfected with siCon or siIft88. (B) Plots depict the expression of Ift88, CD63, and CD81 from western blots in (A) (n = 3). (C) A representative western blot result of CD63 and CD81, analyzed using EVs isolated from the conditioned medium of BV2 cells transfected with siCon or siIft88. (D) Plots depict the expression of CD63 and CD81 from western blots in (C) (n = 3). (E) Western blot analysis of Aβ uptake, analyzed using lysates of BV2 cells transfected with siCon or siIft88, followed by treatment with 1 μM Aβ for 18 h. A plot depicts Aβ in cell lysates (n = 3). (F) Western blot analysis of Aβ secretion in EVs, analyzed using the EVs collected from the conditioned medium of the BV2 cells transfected with siCon or siIft88, followed by treatment with 1 μM Aβ for 18 h. A plot depicts the Aβ obtained in EVs (n = 4). (G) Representative images of Aβ phagocytosis and lysosome activity in BV2 cells after Ift88 inhibition. BV2 cells were transfected with siCon or siIft88, followed by treatment with 1 µM pHrodo-Aβ for 18 h. Fixed cells were stained for pHrodo-Aβ and LysoTracker to visualize the phagocytosis activity and lysosome activity, respectively. (H), (I) Plots depict the relative intensity of pHrodo-Aβ (H) and LysoTracker (I) (n = 4). Data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, ns (non-significant). Scale bars = 10 µm.CC BY · PubMed Central
FIGURE 6 Proteomic analysis of cell lysates and EVs of BV2 cells transfected with siIft88 followed by treatment with Aβ (A) An experimental scheme shows proteomic analysis of cell lysates (n = 4, each group) and EVs (n = 4, each group) collected from the culture medium of BV2 cells after Ift88 inhibition combined with Aβ treatment. (B) Venn diagram indicating the number of identified proteins in BV2 cell lysates and EVs. Samples were obtained from BV2 cells after transfection with siCon or siIft88 followed by treatment with Aβ. (C) The volcano plot depicts the differentially expressed proteins in siIft8-transfected BV2 cell lysates by Aβ treatment. The cut-off values were determined by adjust p-value <0.05, and log2 (fold change) ≥ 0.25 (upregulated) or log2 (fold change) ≤ −0.25 (downregulated). (D) Up- and downregulated proteins were analyzed for enriched pathways using Enrichr (https://maayanlab.cloud/Enrichr/). Significantly enriched clusters (p-value <0.01) for up- and downregulated proteins are indicated in each graph. Representative proteins in each term of the ontology were marked with the same color in the volcano plot. (E) The volcano plot depicts the differentially expressed proteins in siIft8-transfected BV2 cells’ EVs by Aβ treatment. The cut-off values were determined by adjust p-value <0.05, and log2 (fold change) ≥ 0.25 (upregulated) or log2 (fold change) ≤ −0.25 (downregulated). (F) Up- and downregulated proteins were analyzed for enriched pathways using Enrichr. Significantly enriched clusters (p-value <0.01) for up- and downregulated proteins are indicated in each graph. Representative proteins in each term of the ontology were marked with the same color in the volcano plot. (G) Representative histograms of EV size distributions collected from BV2 cells transfected with siCon or siIft88 followed by treatment with or without Aβ (1 µM). The average size of EVs is presented above each histogram. (H) Statistical analysis of concentration (particles/ml) and average size of EVs isolated from the conditioned medium of BV2 cells, transfected with siCon or siIft88, and treated with or without Aβ (1 µM). Data represent means ± SEM, and p-values were calculated by two-way analysis of variance (ANOVA) followed by Turkey’s multiple comparison test. **p < 0.01, *p < 0.05.
FIGURE 6 Proteomic analysis of cell lysates and EVs of BV2 cells transfected with siIft88 followed by treatment with Aβ (A) An experimental scheme shows proteomic analysis of cell lysates (n = 4, each group) and EVs (n = 4, each group) collected from the culture medium of BV2 cells after Ift88 inhibition combined with Aβ treatment. (B) Venn diagram indicating the number of identified proteins in BV2 cell lysates and EVs. Samples were obtained from BV2 cells after transfection with siCon or siIft88 followed by treatment with Aβ. (C) The volcano plot depicts the differentially expressed proteins in siIft8-transfected BV2 cell lysates by Aβ treatment. The cut-off values were determined by adjust p-value <0.05, and log2 (fold change) ≥ 0.25 (upregulated) or log2 (fold change) ≤ −0.25 (downregulated). (D) Up- and downregulated proteins were analyzed for enriched pathways using Enrichr (https://maayanlab.cloud/Enrichr/). Significantly enriched clusters (p-value <0.01) for up- and downregulated proteins are indicated in each graph. Representative proteins in each term of the ontology were marked with the same color in the volcano plot. (E) The volcano plot depicts the differentially expressed proteins in siIft8-transfected BV2 cells’ EVs by Aβ treatment. The cut-off values were determined by adjust p-value <0.05, and log2 (fold change) ≥ 0.25 (upregulated) or log2 (fold change) ≤ −0.25 (downregulated). (F) Up- and downregulated proteins were analyzed for enriched pathways using Enrichr. Significantly enriched clusters (p-value <0.01) for up- and downregulated proteins are indicated in each graph. Representative proteins in each term of the ontology were marked with the same color in the volcano plot. (G) Representative histograms of EV size distributions collected from BV2 cells transfected with siCon or siIft88 followed by treatment with or without Aβ (1 µM). The average size of EVs is presented above each histogram. (H) Statistical analysis of concentration (particles/ml) and average size of EVs isolated from the conditioned medium of BV2 cells, transfected with siCon or siIft88, and treated with or without Aβ (1 µM). Data represent means ± SEM, and p-values were calculated by two-way analysis of variance (ANOVA) followed by Turkey’s multiple comparison test. **p < 0.01, *p < 0.05.CC BY · PubMed Central
FIGURE 7 Proteomic analysis of CD63 or CD81-associated proteins in cell lysates (n = 4, each group) and EVs (n = 4, each group) of BV2 cells transfected with siIft88 in combination with Aβ (A) An experimental scheme describes the identification of CD63 or CD81 binding proteins by LCMS. (B) Western blot analysis of CD63 IP using cell lysates and EVs shows binding of Aβ with CD63 using cell lysates or EVs. CD63 IP using EVs shows CD63 EVs contain Aβ and other EVs, as revealed by Aβ in the flow-through fraction. (C), D) Venn diagram and volcano plot of CD63-binding proteins in cell lysates (C) and EVs (D) show identified proteins in upregulated proteins (adjust p-value <0.05, log2 (fold change) ≥ 0.25) or downregulated proteins (adjust p-value <0.05, log2 (fold change) ≤ −0.25) from BV cells, which were transfected with siIft88 followed by treatment with Aβ (1 µM), compared with BV2 cells transfected with siCon and treated with Aβ (1 µM). (E, F) GO pathway enrichment analysis of CD63-binding proteins (E) and CD81-binding proteins (F). Up- and downregulated proteins were analyzed separately using the Enrichr. Significantly enriched clusters (p-value <0.01) for up- and downregulated proteins are indicated in each graph. Representative proteins for each GO term were color-coded and marked in the volcano plot as well. (G, H) PPI network analysis using the STRING database reveals a network among the selected GO enrichment pathways of CD63-binding proteins (G) and CD81-binding proteins (H) in the cell lysates and EVs.
FIGURE 7 Proteomic analysis of CD63 or CD81-associated proteins in cell lysates (n = 4, each group) and EVs (n = 4, each group) of BV2 cells transfected with siIft88 in combination with Aβ (A) An experimental scheme describes the identification of CD63 or CD81 binding proteins by LCMS. (B) Western blot analysis of CD63 IP using cell lysates and EVs shows binding of Aβ with CD63 using cell lysates or EVs. CD63 IP using EVs shows CD63 EVs contain Aβ and other EVs, as revealed by Aβ in the flow-through fraction. (C), D) Venn diagram and volcano plot of CD63-binding proteins in cell lysates (C) and EVs (D) show identified proteins in upregulated proteins (adjust p-value <0.05, log2 (fold change) ≥ 0.25) or downregulated proteins (adjust p-value <0.05, log2 (fold change) ≤ −0.25) from BV cells, which were transfected with siIft88 followed by treatment with Aβ (1 µM), compared with BV2 cells transfected with siCon and treated with Aβ (1 µM). (E, F) GO pathway enrichment analysis of CD63-binding proteins (E) and CD81-binding proteins (F). Up- and downregulated proteins were analyzed separately using the Enrichr. Significantly enriched clusters (p-value <0.01) for up- and downregulated proteins are indicated in each graph. Representative proteins for each GO term were color-coded and marked in the volcano plot as well. (G, H) PPI network analysis using the STRING database reveals a network among the selected GO enrichment pathways of CD63-binding proteins (G) and CD81-binding proteins (H) in the cell lysates and EVs.CC BY · PubMed Central
FIGURE 8 Increased Aβ plaques and dystrophic neurites in the LS of Ift88-flox/flox; 5xFAD (10-month-old) 1 month after intracerebroventricular (ICV) administration of AAV-pCD68-Cre (A) A schematic drawing illustrates the stereotaxic injection of AAV-pCD68-Cre into the lateral ventricle of Ift88-flox/flox; 5xFAD mice and the examination of the septal region after 1 month. (B) Representative low magnification images of the LS for Aβ plaques (D54D2, white), cored Aβ plaques (Amylo-Glo, blue), and dystrophic neurites (Lamp1, red) in 5xFAD (sham) (10-month-old, n = 3, one male and two females) and Ift88-flox/flox; 5xFAD (10-month-old, n = 3, one male and two females), injected with AAV-pCD68-Cre. (C) Representative images of dystrophic neurites (Lamp1, red) adjacent to Aβ plaques (D54D2, white). The cored Aβ plaques were counter-stained using Amylo-Glo (blue). (D) Plots depict the number of Aβ plaques marked with D54D2 and Amylo-Glo. The seeded Amylo-Glo-positive (≤50 µm) and growing cored plaques (≥200 µm) were measured. A plot depicts Lamp1-labeled dystrophic neurites as shown by the area ratio (Lamp1/D54D2) in each plaque in 5xFAD (sham) (10-month-old, n = 3, one male and two females) and Ift88-flox/flox; 5xFAD (10-month-old, n = 3, one male and two females), injected with AAV-pCD68-Cre. (E) Representative images of Aβ plaque (Amylo-Glo, blue)-associated microglia (Iba1, red) in the LS of 5xFAD (sham) (10-month-old, n = 3, one male and two females) and Ift88-flox/flox; 5xFAD mice (10-month-old, n = 3, one male and two females), injected with AAV-pCD68-Cre. (F) A plot depicts the number of microglia adjacent to each Aβ plaque. (G) Representative images of PSVue-550, CD63, and CD81 show the vesicular coverage in the Amylo-Glo-positive plaques of the cortex and the LS. (H) Plots depict the intensity of PSVue-550 that binds phosphatidylserine of EVs and EV markers, such as CD63 and CD81, in the cortex and the LS of 5xFAD (sham) (10-month-old, n = 3) and Ift88-flox/flox; 5xFAD (10-month-old, n = 3) injected with AAV-pCD68-Cre. (D, F, H) The data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. ****p < 0.0001, *p < 0.05. Scale bars = 100 ㎛ (B); 10 ㎛ (C, E, G).
FIGURE 8 Increased Aβ plaques and dystrophic neurites in the LS of Ift88-flox/flox; 5xFAD (10-month-old) 1 month after intracerebroventricular (ICV) administration of AAV-pCD68-Cre (A) A schematic drawing illustrates the stereotaxic injection of AAV-pCD68-Cre into the lateral ventricle of Ift88-flox/flox; 5xFAD mice and the examination of the septal region after 1 month. (B) Representative low magnification images of the LS for Aβ plaques (D54D2, white), cored Aβ plaques (Amylo-Glo, blue), and dystrophic neurites (Lamp1, red) in 5xFAD (sham) (10-month-old, n = 3, one male and two females) and Ift88-flox/flox; 5xFAD (10-month-old, n = 3, one male and two females), injected with AAV-pCD68-Cre. (C) Representative images of dystrophic neurites (Lamp1, red) adjacent to Aβ plaques (D54D2, white). The cored Aβ plaques were counter-stained using Amylo-Glo (blue). (D) Plots depict the number of Aβ plaques marked with D54D2 and Amylo-Glo. The seeded Amylo-Glo-positive (≤50 µm) and growing cored plaques (≥200 µm) were measured. A plot depicts Lamp1-labeled dystrophic neurites as shown by the area ratio (Lamp1/D54D2) in each plaque in 5xFAD (sham) (10-month-old, n = 3, one male and two females) and Ift88-flox/flox; 5xFAD (10-month-old, n = 3, one male and two females), injected with AAV-pCD68-Cre. (E) Representative images of Aβ plaque (Amylo-Glo, blue)-associated microglia (Iba1, red) in the LS of 5xFAD (sham) (10-month-old, n = 3, one male and two females) and Ift88-flox/flox; 5xFAD mice (10-month-old, n = 3, one male and two females), injected with AAV-pCD68-Cre. (F) A plot depicts the number of microglia adjacent to each Aβ plaque. (G) Representative images of PSVue-550, CD63, and CD81 show the vesicular coverage in the Amylo-Glo-positive plaques of the cortex and the LS. (H) Plots depict the intensity of PSVue-550 that binds phosphatidylserine of EVs and EV markers, such as CD63 and CD81, in the cortex and the LS of 5xFAD (sham) (10-month-old, n = 3) and Ift88-flox/flox; 5xFAD (10-month-old, n = 3) injected with AAV-pCD68-Cre. (D, F, H) The data represent means ± SEM, and p-values were calculated by an unpaired two-tailed t-test. ****p < 0.0001, *p < 0.05. Scale bars = 100 ㎛ (B); 10 ㎛ (C, E, G).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 109 references

Research works printed but not linked: 3

  1. Lewis, 2023, EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling". R package version 1.18.0
  2. Wickham, 2016, ggplot2: elegant Graphics for Data Analysis
  3. Yajima, 2023, Mast: model-Based analysis of single cell transcriptomics". R package version 1.26.0

Cited by

See all 21

Metadata

Authors
Yeo, S., Jang, J., Jung, H. J., Lee, H., & Choe, Y.
Affiliations
  • Korea Brain Research Institute (KR)
  • Dong-Eui University (KR)
Corresponding author
Choe, Youngshik
Venue
Frontiers in Molecular Biosciences
Published
2023-10-23
Volume
10
Pages
1250335-1250335
ISSN
2296-889X (ISSN-L)
OpenAlex
W4387906417
Cited by
18
References
109
Citations by year
2026: 7 · 2025: 8 · 2024: 3
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Molecular Biosciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Korea Brain Research Institute (23-BR-03-05, 23-BR-02-01)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, primary cilia, microglia, disease-associated microglia, lateral septum, amyloid plaques, IFT88, secretome, neuroinflammation, hippocampus, proteostasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary cilia-mediated regulation of microglial secretion in Alzheimer’s disease. https://app.cochat.ai/papers/10.3389/fmolb.2023.1250335
The paper
Yeo, S., Jang, J., Jung, H. J., Lee, H., & Choe, Y. (2023). Primary cilia-mediated regulation of microglial secretion in Alzheimer’s disease. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2023.1250335

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.